Hpr Medicines Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 09-01-2025
- Paid Up Capital ₹ 2.00 M
as on 09-01-2025
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 56.93%
(FY 2022)
- Ebitda 3.11%
(FY 2022)
- Net Worth 7.07%
(FY 2022)
- Total Assets 30.70%
(FY 2022)
About Hpr Medicines
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Aniket Sonar and Abhijit Sonar serve as directors at the Company.
- CIN/LLPIN
U24233MH2007PTC170238
- Company No.
170238
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Apr 2007
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hpr Medicines?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aniket Sonar  | Director | 03-Jan-2011 | Current |
| Abhijit Sonar | Director | 24-Dec-2020 | Current |
Financial Performance of Hpr Medicines.
Hpr Medicines Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 56.93% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 7.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hpr Medicines?
In 2020, Hpr Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hpr Medicines?
Unlock and access historical data on people associated with Hpr Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hpr Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hpr Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
